Professor | Lv Jiadi | Asia Growth Partners

Upload Avatar (500 x 500)

Name

Lv Jiadi

Contact Information

lvjiadi666@aliyun.com

Language ability

Chinese, English

Province

Beijing

University/Lab Affiliation and Title	Peking Union Medical College
Faculty	Basic Medical Sciences
Academic Background & Achievements	2022-present: Associate Researcher at Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences 2021-2022: Assistant Researcher at Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences 2018-2021: Postdoctoral Researcher at Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences 2015-2018: PhD in Immunology from Peking Union Medical College 2012-2015: Master's in Pharmacology from China Pharmaceutical University 2008-2012: Bachelor's in Pharmaceutical Engineering from Jilin Agricultural University
Work Experience	2022-present: Associate Researcher at Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences 2021-2022: Assistant Researcher at Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences 2018-2021: Postdoctoral Researcher at Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences
Awards	2023: Elected as a member of the 11th Council of the Chinese Society of Biomedical Engineering 2023: Received the 11th Young Scholar Award from the Chinese Society of Immunology 2022: Selected for the 7th Youth Talent Support Program by the China Association for Science and Technology

University/Lab Affiliation and Title

Peking Union Medical College

Faculty

Basic Medical Sciences

Academic Background & Achievements

2022-present: Associate Researcher at Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences
2021-2022: Assistant Researcher at Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences
2018-2021: Postdoctoral Researcher at Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences
2015-2018: PhD in Immunology from Peking Union Medical College
2012-2015: Master's in Pharmacology from China Pharmaceutical University
2008-2012: Bachelor's in Pharmaceutical Engineering from Jilin Agricultural University

Work Experience

2022-present: Associate Researcher at Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences
2021-2022: Assistant Researcher at Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences
2018-2021: Postdoctoral Researcher at Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences

Awards

2023: Elected as a member of the 11th Council of the Chinese Society of Biomedical Engineering
2023: Received the 11th Young Scholar Award from the Chinese Society of Immunology
2022: Selected for the 7th Youth Talent Support Program by the China Association for Science and Technology

Areas of Focus	Biomechanics and Tumor Immunology
Publications	Gasdermin E mediates resistance of pancreatic adenocarcinoma to enzymatic digestion through a YBX1-mucin pathway., Lv J, Liu Y, Mo S, Zhou Y, Chen F, Tong WM & Huang B., 2022 Epigenetic modification of CSDE1 locus dictates immune recognition of nascent tumorigenic cells., Lv J, Zhou Y, Zhou N, Wang Z, Chen J, Tang K, Ma J, Liu J, Wan Y, Zhang Y, Zhang H, Huang B., 2023 Cell softness regulates tumorigenicity and stemness of cancer cells., Lv J, Liu Y, Cheng F, Li J, Zhou Y, Zhang T, Fang Y, Zhang H, Wang N, Liu Y & Huang, B., 2021 Distinct uptake, amplification, and release of SARS-CoV-2 by M1 and M2 alveolar macrophages., Lv J, Wang Z, Qu Y, Zhu H, Zhu Q, Tong W, Tong, WM, Liu J, Liu Y, Qin C & Huang B., 2021 ACE2 expression is regulated by AhR in SARS-CoV-2-infected macaques., Lv J, Yu P, Wang Z, Deng W, Bao L, Liu J, Li F, Zhu Q, Tong WM, Liu Y, Qin C & Huang B., 2021

Areas of Focus

Biomechanics and Tumor Immunology

Publications

Gasdermin E mediates resistance of pancreatic adenocarcinoma to enzymatic digestion through a YBX1-mucin pathway., Lv J*, Liu Y*, Mo S*, Zhou Y, Chen F, Tong WM & Huang B., 2022
Epigenetic modification of CSDE1 locus dictates immune recognition of nascent tumorigenic cells., Lv J*, Zhou Y*, Zhou N, Wang Z, Chen J, Tang K, Ma J, Liu J, Wan Y, Zhang Y, Zhang H, Huang B., 2023
Cell softness regulates tumorigenicity and stemness of cancer cells., Lv J*, Liu Y*, Cheng F*, Li J, Zhou Y, Zhang T, Fang Y, Zhang H, Wang N, Liu Y & Huang, B., 2021
Distinct uptake, amplification, and release of SARS-CoV-2 by M1 and M2 alveolar macrophages., Lv J*, Wang Z*, Qu Y*, Zhu H, Zhu Q, Tong W, Tong, WM, Liu J, Liu Y, Qin C & Huang B., 2021
ACE2 expression is regulated by AhR in SARS-CoV-2-infected macaques., Lv J*, Yu P*, Wang Z*, Deng W, Bao L, Liu J, Li F, Zhu Q, Tong WM, Liu Y, Qin C & Huang B., 2021

Biomechanics Tumor Immunology Cancer Stem Cells Immune Evasion Pancreatic Cancer Sars-Cov-2 Tumorigenicity Cell Softness

Huang Bo - Peking Union Medical College

Yuying Liu - Peking Union Medical College

Fang Ni - University of Science and Technology of China

View All

Personal Information